Digital Health Startups

Palleon Pharma develops small molecule and biologic drugs targeting autoimmune and inflammatory diseases using proprietary glycoscience platforms. The company serves patients with conditions including systemic lupus erythematosus, rheumatoid arthritis, and other autoimmune disorders.

2 investors

Palo Santo is a venture capital firm that invests in neuroscience and mental health companies, focusing on novel CNS therapeutics, next-generation psychedelic therapies, and brain health technologies. The firm targets solutions addressing the innovation gap in mental health treatment and psychiatric disorders.

2 investors

Pandia Health is a doctor-founded, women-led telehealth service that provides online consultations with board-certified physicians specializing in hormonal and reproductive care, along with free home delivery of prescriptions. It offers personalized hormone therapy for needs such as birth control, hormonal balance, menopause, and sexual wellness, using medication-matching technology and patient data.

2 investors

Pando is a secure messaging and clinical collaboration platform that lets clinicians communicate with each other and connects patients to specialists. It serves healthcare organisations and professionals, with usage across NHS hospitals, clinics and communities in the UK.

2 investors

Pangaea Data provides an AI-powered platform that analyzes electronic health records and clinical guidelines to identify untreated and under-treated patients across prevalent and rare conditions. The platform processes unstructured and structured EHR data with clinically validated reasoning to help healthcare providers discover patient needs with privacy preservation and no disruption to existing workflows.

2 investors

PANTHERx is an independent specialty pharmacy focused on rare disease care, dispensing and managing therapies for patients with rare conditions across the US. Licensed in all 50 states, it serves patients, prescribers, and manufacturers through a personalized "Rare Pharmacy" model.

2 investors

Papaya provides an operating system for insurance built on four interconnected intelligence systems—claims processing, fraud detection, underwriting automation, and partner distribution—that automate claim adjudication, fraud screening, and underwriting with AI agents. The platform serves insurance carriers and underwriters seeking to reduce manual claim processing and improve underwriting speed.

2 investors

Paradigm Health is an Indiana-based hospice and palliative care provider offering community-based, holistic care to patients and support for their families and caregivers. It provides end-of-life hospice services, palliative care, bereavement support, volunteer programs, and enrichment offerings, and is accredited by the Accreditation Commission for Health Care.

2 investors

Paradigm develops diagnostic tests for cancer, including assessments of hereditary risk, screening for the presence of cancer, and analysis of the genomic alterations in a patient's tumor to help guide treatment decisions. The company operates in the cancer diagnostics and genomics industry.

2 investors

Parallel Health offers a skincare product line addressing aging through microbiome science, including peptide creams and cleansers designed to target the hallmarks of skin aging.

2 investors

Parexel is a contract research organization (CRO) providing clinical development, regulatory consulting, and market access services for biopharmaceutical companies conducting clinical trials across phases I-IV globally. The company operates with a network of offices and specialized facilities across North America, Latin America, Europe, and Asia-Pacific.

2 investors

Partum Health provides comprehensive whole-person care for growing families, offering services such as postpartum specialist visits, in-home lactation support, physical therapy, and mental health care across the pregnancy and postpartum journey. It serves parents and families in the United States.

2 investors

Path Fertility develops diagnostic tests for male reproductive health, using sperm epigenetics technology to identify subfertility that standard analysis misses. The tests enable earlier and more accurate diagnosis for couples pursuing fertility treatment.

2 investors

PathPresenter is a digital pathology platform used for viewing, sharing, and managing pathology images in clinical, research, and educational settings. It serves pathologists and healthcare/medical organizations in the digital and computational pathology field.

2 investors

Patient21 develops a digital platform to help clinics operate and connect for value-based healthcare, removing administrative burdens from physicians to improve the doctor-patient relationship. The company serves outpatient clinics and healthcare providers across multiple medical specialties.

2 investors

PatientOne provides a remote patient monitoring solution for healthcare providers and organizations focused on value-based care delivery. The platform enables real-time monitoring of patient health data to support cost reduction, early intervention, and improved patient outcomes.

2 investors

PatientSource provides a cloud-based diagnostic testing module for healthcare settings that manages radiology, pathology, cardiology, and other clinical tests. The platform integrates with existing healthcare systems and uses AI to assist diagnosis and detect clinical deterioration, serving NHS trusts and other healthcare providers.

2 investors

PatientWisdom provides an EHR-integrated patient experience tool that summarizes patient context, risks, and past experiences (MyView) and collects patient-generated information (MyStory) so care teams can prepare for and personalize visits. It is sold to health systems and integrates with major EHR platforms.

2 investors

PCaVision combines multiparametric ultrasound imaging with AI algorithms to detect suspicious areas for prostate cancer, offering a diagnostic pathway for urologists that avoids the need for MRI. It targets clinics, hospitals, and urologists, and is CE/MDR Class IIb certified for use in authorized EU markets.

2 investors

Peak Health offers doctor-led longevity care combining advanced diagnostic testing (labs, biomarkers, DEXA scans, VO2 max) with personalized treatment plans including hormones, peptides, GLP-1s, supplements, nutrition, and fitness, all managed through a single health data platform. It serves consumers seeking proactive aging, hormone optimization, and disease prevention, and also offers infrastructure for clinical practices to launch or expand longevity programs.

2 investors

Peak Medical develops AI-powered healthcare technology designed to improve diagnostic and treatment accessibility in underserved populations. The company focuses on affordable, sensor-free solutions that address health equity and reduce barriers to care regardless of geographic location or financial constraints.

2 investors

PediaMetrix operates a directory that connects families with verified pediatric specialists searchable by zip code, and offers a suite of informational assessment tools for parents to track infant and child developmental conditions. The company serves parents and pediatric care providers with app-based screening tools and a provider network.

2 investors

Pediatrics Plus provides pediatric therapy services and preschool programs for children, operating multiple locations across Arkansas. The company offers occupational, physical, and speech therapy alongside developmental preschool care.

2 investors

Penda Health operates a network of medical centers in Nairobi providing outpatient, home-based, specialist, and diagnostic care, along with telemedicine, to patients and corporate partners. It offers wellness packages and capitation-based plans for employers and accepts most insurance plans, positioning itself as one of the largest outpatient healthcare providers in East Africa.

2 investors